Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Rouxs Arch Dev Biol
1995 Jan 01;2043:198-202. doi: 10.1007/BF00241273.
Show Gene links
Show Anatomy links
Fission yeast tmsl protein abrogates normal development in Xenopus laevis embryos.
Wagner P
,
Hoever M
,
Appel K
,
Knöchel W
,
Montenarh M
.
???displayArticle.abstract???
Recently we cloned tms1 (a putative dehydrogenase) by complementation of a human tumour-derived mutant p53 induced growth arrest in fission yeast. Microinjection of purified tmsl protein into Xenopus laevis embryos abrogated normal embryo development by causing cleavage retardation or cleavage arrest of injected blastomeres in a concentration dependant manner, whereas injection of specific affinity purified tms1 antiserum showed no significant morphological defects. Microinjection of tms1 protein together with affinity purified tms1 antibody resulted in a significantly reduced number of cleavage arrested embryos.
Appel,
A new 42-kda protein-binding to the growth suppressor protein-p53.
1994, Pubmed
Appel,
A new 42-kda protein-binding to the growth suppressor protein-p53.
1994,
Pubmed
Cross,
Simple and complex cell cycles.
1989,
Pubmed
Donehower,
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
1992,
Pubmed
Duester,
Intron-dependent evolution of the nucleotide-binding domains within alcohol dehydrogenase and related enzymes.
1986,
Pubmed
Finlay,
The p53 proto-oncogene can act as a suppressor of transformation.
1989,
Pubmed
Hinds,
Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
1989,
Pubmed
Hoever,
Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos.
1994,
Pubmed
,
Xenbase
Lane,
Cancer. p53, guardian of the genome.
1992,
Pubmed
Levine,
The tumor suppressor genes.
1993,
Pubmed
Mercer,
Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
1990,
Pubmed
Michalovitz,
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.
1990,
Pubmed
Montenarh,
Functional implications of the growth-suppressor oncoprotein p53.
1992,
Pubmed
Norbury,
Animal cell cycles and their control.
1992,
Pubmed
Soussi,
Structural aspects of the p53 protein in relation to gene evolution.
1990,
Pubmed
Studier,
Use of T7 RNA polymerase to direct expression of cloned genes.
1990,
Pubmed
Wagner,
Putative dehydrogenase tms1 suppresses growth arrest induced by a p53 tumour mutant in fission yeast.
1993,
Pubmed
Wagner,
P53 forms tight complexes with tms1 of fission yeast.
1994,
Pubmed
Wagner,
Ypt proteins in yeast.
1992,
Pubmed
Wagner,
A human tumour-derived mutant p53 protein induces a p34cdc2 reversible growth arrest in fission yeast.
1991,
Pubmed
Wolf,
Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species.
1984,
Pubmed
